Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses

European Journal of Immunology

Volumn 33, Issue 10, 2003, Pages 2773-2782

  Tsushima, Fumihiko ^a   Iwai, Hideyuki ^a   Otsuki, Noriko ^a   Abe, Masaaki ^b   Hirose, Sachiko ^b   Yamazaki, Tomohide ^b   Akiba, Hisaya ^b   Yagita, Hideo ^b   Takahashi, Yuzo ^a   Omura, Ken ^a   Okumura, Ko ^b   Azuma, Miyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contract hypersensitivity; Dendritic cells; Regulation; Tolerance

Indexed keywords

B7 ANTIGEN; B7 DC ANTIGEN; B7 H1 ANTIGEN; CD28 ANTIGEN; HAPTEN; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; B7-DC ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PDCD1 PROTEIN, MOUSE; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE; PLASMA PROTEIN; PROTEIN;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL INTERACTION; CONTACT ALLERGY; CONTACT SENSITIZATION; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; CONTACT DERMATITIS; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; BLOOD PROTEINS; DERMATITIS, CONTACT; FEMALE; HAPTENS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PEPTIDES; PROTEINS;

EID: 0242366612     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324084     Document Type: Article

References (39)

1. Chambers, C. A., The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol. 2001. 22: 217-223.
2. Liang, L. and Sha, W. C., The right place at the right time: novel B7 family members regulate effector T cell responses. Curr. Opin. Immunol. 2002. 14: 384-390.
3. Salomon, B. and Bluestone, J. A., Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 2001. 19: 225-252.
4. Chambers, C. A., Kuhns, M. S., Egen, J. G. and Allison, J. P., CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 2001. 19: 565-594.
5. Egen, J. G., Kuhns, M. S. and Allison, J. P., CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 2002. 3: 611-618.
6. Ishida, Y., Agata, Y., Shibahara, K. and Honjo, T., Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992. 11: 3887-3895.
7. Nishimura, H. and Honjo, T., PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 2001. 22: 265-268.
8. Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999. 11: 141-151.
9. Sharpe, A. H. and Freeman, G. J., The B7-CD28 superfamily. Nat. Rev. Immunol. 2002. 2: 116-126.
10. -) thymocytes. Int. Immunol. 1996. 8: 773-780.
11. Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata, T., Yagita, H. and Honjo, T., Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 1996. 8: 765-772.
12. Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N. and Honjo, T., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001. 291: 319-322.
13. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H., Loss of CTLA-4 leads to massive lymphoproliferation and fetal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541-547.
14. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, A. P., Thompson, C. B., Griesser, H. and Mak, T. W., Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995. 270: 985-988.
15. + T cells. Immunity 1997. 7: 885-895.
16. Dong, H., Zhu, G., Tamada, K. and Chen, L., B7-H1, a third member of the B7 family, co-stimulates T cell proliferation and interleukin-10 secretion [see comments]. Nat. Med. 1999. 5: 1365-1369.
17. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R., Carreno, B. M., Collins, M., Wood, C. R. and Honjo, T., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 1027-1034.
18. Tseng, S. Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M. and Tsuchiya, H., B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 2001. 193: 839-846.
19. Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., Greenfield, E. A., Bourque, K., Boussiotis, V. A., Carter, L. L., Carreno, B. M., Malenkovich, N., Nishimura, H., Okazaki, T., Honjo, T., Sharpe, A. H. and Freeman, G. J., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261-268.
20. Ishida, M., Iwai, Y., Tanaka, Y., Okazaki, T., Freeman, G., Minato, N. and Honjo, T., Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol. Lett 2002. 84: 57-62.
21. Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., Lennon, V. A., Celis, E. and Chen, L., Tumor-associated B7-H1 promotes T cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 2002. 8: 793-800.
22. Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., Azuma, M. and Yagita, H., Expression of PD-1 ligands by murine T cells and antigen-presenting cells. J. Immunol. 2002. 169: 5538-5545.
23. Tamura, H., Dong, H., Zhu, G., Sica, G. L., Flies, D. B., Tamada, K. and Chen, L., B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 2001. 97: 1809-1816.
24. Nuriya, S., Yagita, H., Okumura, K. and Azuma, M., The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int. Immunol. 1996. 8: 917-926.
25. Nuriya, S., Enomoto, S. and Azuma, M., The role of CTLA-4 in murine contact hypersensitivity. J. Invest. Dermatol. 2001. 116: 764-768.
26. Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A. and Freeman, G. J., Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003. 170: 1257-1266.
27. Weinlich, G., Heine, M., Stossel, H., Zanella, M., Stoitzner, P., Ortner, U., Smolle, J., Koch, F., Sepp, N. T., Schuler, G. and Romani, N., Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J. Invest. Dermatol. 1998. 110: 441-448.
28. Carter, L., Fouser, L., Jussif, J., Fitz, L., Deng, B., Wood, C., Collins, M., Honjo, T., Freeman, G. and Carreno, B., PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2. Eur. J. Immunol. 2002. 32: 634-643.
29. Ozkaynak, E., Wang, L., Goodearl, A., McDonald, K., Qin, S., O'Keefe, T., Duong, T., Smith, T., Gutierrez-Ramos, J. C., Rottman, J. B., Coyle, A. J. and Hancock, W. W., Programmed death-1 targeting can promote allograft survival. J. Immunol. 2002. 169: 6546-6553.
30. Jonuleit, H., Schmitt, E., Steinbrink, K. and Enk, A. H., Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001. 22: 394-400.
31. Lutz, M. and Schuler, G., Immature, semi-mature, and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002. 23: 445.
32. Lespagnard, L., Mettens, P., De Smedt, T., Bazin, H., Urbain, J., Leo, O. and Moser, M., The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance. Int. Immunol. 1998. 10: 295-304.
33. Iwai, Y., Okazaki, T., Nishimura, H., Kawasaki, A., Yagita, H. and Honjo, T., Microanatomical localization of PD-1 in human tonsils. Immunol. Lett 2002. 83: 215-220.
34. Dong, H., Strome, S. E., Matteson, E. L., Moder, K. G., Flies, D. B., Zhu, G., Tamura, H., Driscoll, C. L. and Chen, L., Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 2003. 111: 363-370.
35. Mazanet, M. M. and Hughes, C. C., B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 2002. 169: 3581-3588.
36. Petroff, M. G., Chen, L., Phillips, T. A., Azzola, D., Sedlmayr, P. and Hunt, J. S., B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol. Reprod. 2002. 68: 1496-1504.
37. Petroff, M. G., Chen, L., Phillips, T. A. and Hunt, J. S., B7 family molecules: novel immunomodulators at the maternal-fetal interface. Placenta 2002. 23 Suppl A: S95-S101.
38. Saito, K., Yagita, H., Hashimoto, H., Okumura, K. and Azuma, M., Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease. Eur. J. Immunol. 1996. 26: 3098-3106.
39. Iwai, H., Kozono, Y., Hirose, S., Akiba, H., Yagita, H., Okumura, K., Kohsaka, H., Miyasaka, N. and Azuma, M., Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J. Immunol. 2002. 169: 4332-4339.